www.fdanews.com/articles/148626-bristol-myers-astrazeneca-expand-diabetes-alliance
Bristol-Myers, AstraZeneca Expand Diabetes Alliance
August 10, 2012
Bristol-Myers Squibb Company and AstraZeneca have announced the completion of the acquisition of Amylin Pharmaceuticals by Bristol-Myers Squibb.
Pharmaceutical Business Review
Pharmaceutical Business Review